{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:39:38Z","timestamp":1792528778752,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-05100-0","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:44:07Z","timestamp":1784886247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined TIPS and TACE for patients with hepatocellular carcinoma and variceal bleeding secondary to portal vein tumor thrombus"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhuyu","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bifei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"1","key":"5100_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/hep.27864","volume":"62","author":"F Faitot","year":"2015","unstructured":"Faitot F, Allard M, Pittau G, et al. Impact of clinically evident portal hypertension on the course of hepatocellular carcinoma in patients listed for liver transplantation. Hepatology. 2015;62(1):179\u201387. https:\/\/doi.org\/10.1002\/hep.27864.","journal-title":"Hepatology"},{"issue":"9930","key":"5100_CR2","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","volume":"383","author":"EA Tsochatzis","year":"2014","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383(9930):1749\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(14)60121-5.","journal-title":"Lancet"},{"issue":"3","key":"5100_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/1751-2980.12223","volume":"16","author":"K Goh","year":"2015","unstructured":"Goh K, Razlan H, Hartono JL, et al. Liver cancer in M alaysia: Epidemiology and clinical presentation in a multiracial A sian population. J Digest Dis. 2015;16(3):152\u20138. https:\/\/doi.org\/10.1111\/1751-2980.12223.","journal-title":"J Digest Dis"},{"issue":"9","key":"5100_CR4","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.4240\/wjgs.v16.i9.2778","volume":"16","author":"ZQ Wu","year":"2024","unstructured":"Wu ZQ, Wang F, Wang FP, et al. Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in patients with hepatocellular carcinoma and portal vein tumor thrombus. World J Gastrointest Surg. 2024;16(9):2778\u201386. https:\/\/doi.org\/10.4240\/wjgs.v16.i9.2778.","journal-title":"World J Gastrointest Surg"},{"issue":"6","key":"5100_CR5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s12664-024-01646-7","volume":"43","author":"S Giri","year":"2024","unstructured":"Giri S, Singh A, Das S, et al. Efficacy and safety of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma\u2014a systematic review and meta-analysis. Indian J Gastroenterol. 2024;43(6):1121\u201335. https:\/\/doi.org\/10.1007\/s12664-024-01646-7.","journal-title":"Indian J Gastroenterol"},{"issue":"4","key":"5100_CR6","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R De Franchis","year":"2022","unstructured":"De Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII \u2013 Renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959\u201374. https:\/\/doi.org\/10.1016\/j.jhep.2021.12.022.","journal-title":"J Hepatol"},{"issue":"1","key":"5100_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358\u201380. https:\/\/doi.org\/10.1002\/hep.29086.","journal-title":"Hepatology"},{"issue":"6","key":"5100_CR8","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1159\/000439101","volume":"33","author":"M Kudo","year":"2015","unstructured":"Kudo M, Kitano M, Sakurai T, Nishida N. General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan. Dig Dis. 2015;33(6):765\u201370. https:\/\/doi.org\/10.1159\/000439101.","journal-title":"Dig Dis"},{"key":"5100_CR9","doi-asserted-by":"publisher","unstructured":"Moore KP, Wong F, Gines P et al. The Management of Ascites in Cirrhosis: Report on the Consensus Conference of the International Ascites Club. Hepatology. 2003;38(1):258\u2013266. https:\/\/doi.org\/10.1053\/jhep.2003.50315.","DOI":"10.1053\/jhep.2003.50315"},{"issue":"4","key":"5100_CR10","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jhep.2017.11.005","volume":"68","author":"JS Bajaj","year":"2018","unstructured":"Bajaj JS. Hepatic encephalopathy: Classification and treatment. J Hepatol. 2018;68(4):838\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2017.11.005.","journal-title":"J Hepatol"},{"issue":"2","key":"5100_CR11","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jhep.2019.09.026","volume":"72","author":"JM Llovet","year":"2020","unstructured":"Llovet JM, Lencioni R. mRECIST for HCC: Performance and novel refinements. J Hepatol. 2020;72(2):288\u2013306. https:\/\/doi.org\/10.1016\/j.jhep.2019.09.026.","journal-title":"J Hepatol"},{"issue":"11","key":"5100_CR12","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1007\/s10620-007-9808-2","volume":"52","author":"D Takizawa","year":"2007","unstructured":"Takizawa D, Kakizaki S, Sohara N, et al. Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Clinical Characteristics, Prognosis, and Patient Survival Analysis. Dig Dis Sci. 2007;52(11):3290\u20135. https:\/\/doi.org\/10.1007\/s10620-007-9808-2.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"5100_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/hep.510290145","volume":"29","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Bustamante J, Castells A, et al. Natural History of Untreated Nonsurgical Hepatocellular Carcinoma: Rationale for the Design and Evaluation of Therapeutic Trials. Hepatology. 1999;29(1):62\u20137. https:\/\/doi.org\/10.1002\/hep.510290145.","journal-title":"Hepatology"},{"issue":"10","key":"5100_CR14","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1007\/s00330-022-08705-7","volume":"32","author":"Z Qiu","year":"2022","unstructured":"Qiu Z, Wang G, Yan H, et al. TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension. Eur Radiol. 2022;32(10):6777\u201387. https:\/\/doi.org\/10.1007\/s00330-022-08705-7.","journal-title":"Eur Radiol"},{"issue":"9","key":"5100_CR15","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s00270-017-1655-8","volume":"40","author":"B Qiu","year":"2017","unstructured":"Qiu B, Li K, Dong X, Liu FQ. Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Cardiovasc Intervent Radiol. 2017;40(9):1372\u201382. https:\/\/doi.org\/10.1007\/s00270-017-1655-8.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"5100_CR16","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.3748\/wjg.v20.i6.1602","volume":"20","author":"JB Zhao","year":"2014","unstructured":"Zhao JB. Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis. WJG. 2014;20(6):1602. https:\/\/doi.org\/10.3748\/wjg.v20.i6.1602.","journal-title":"WJG"},{"issue":"6","key":"5100_CR17","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/hepr.12162","volume":"44","author":"L Liu","year":"2014","unstructured":"Liu L, Zhao Y, Qi X, et al. Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis. Hepatol Res. 2014;44(6):621\u201330. https:\/\/doi.org\/10.1111\/hepr.12162.","journal-title":"Hepatol Res"},{"key":"5100_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/398172","volume":"2013","author":"P Peter","year":"2013","unstructured":"Peter P, Andrej Z, Katarina \u0160P, Manca G, Pavel S. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with recurrent variceal hemorrhage. Gastroenterol Res Pract. 2013;2013:1\u20135. https:\/\/doi.org\/10.1155\/2013\/398172.","journal-title":"Gastroenterol Res Pract"},{"issue":"4","key":"5100_CR19","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10620-014-3391-0","volume":"60","author":"LC Casadaban","year":"2015","unstructured":"Casadaban LC, Parvinian A, Minocha J, et al. Clearing the confusion over hepatic encephalopathy after TIPS creation: Incidence, prognostic factors, and clinical outcomes. Dig Dis Sci. 2015;60(4):1059\u201366. https:\/\/doi.org\/10.1007\/s10620-014-3391-0.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"5100_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jvir.2020.09.007","volume":"32","author":"AC Gordon","year":"2021","unstructured":"Gordon AC, Gupta AN, Gabr A, et al. Safety and efficacy of segmental yttrium-90 radioembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol. 2021;32(2):211\u20139. https:\/\/doi.org\/10.1016\/j.jvir.2020.09.007.","journal-title":"J Vasc Interv Radiol"},{"issue":"Supplement 3","key":"5100_CR21","doi-asserted-by":"publisher","first-page":"S344","DOI":"10.1097\/MCG.0b013e318157e500","volume":"41","author":"L Colombato","year":"2007","unstructured":"Colombato L. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension. J Clin Gastroenterol. 2007;41(Supplement 3):S344\u201351. https:\/\/doi.org\/10.1097\/MCG.0b013e318157e500.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"5100_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/apt.12994","volume":"41","author":"D Bettinger","year":"2015","unstructured":"Bettinger D, Kn\u00fcppel E, Euringer W, et al. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma. Aliment Pharmacol Ther. 2015;41(1):126\u201336. https:\/\/doi.org\/10.1111\/apt.12994.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"5100_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jhep.2010.06.029","volume":"54","author":"G Han","year":"2011","unstructured":"Han G, Qi X, He C, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol. 2011;54(1):78\u201388. https:\/\/doi.org\/10.1016\/j.jhep.2010.06.029.","journal-title":"J Hepatol"},{"issue":"6","key":"5100_CR24","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1136\/gut.2010.228023","volume":"60","author":"A Luca","year":"2011","unstructured":"Luca A, Miraglia R, Caruso S, et al. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut. 2011;60(6):846\u201352. https:\/\/doi.org\/10.1136\/gut.2010.228023.","journal-title":"Gut"},{"issue":"3","key":"5100_CR25","doi-asserted-by":"publisher","first-page":"100264","DOI":"10.1016\/j.jhepr.2021.100264","volume":"3","author":"M Praktiknjo","year":"2021","unstructured":"Praktiknjo M, Abu-Omar J, Chang J, et al. Controlled underdilation using novel VIATORR\u00ae controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation. JHEP Rep. 2021;3(3):100264. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100264.","journal-title":"JHEP Rep"},{"issue":"1","key":"5100_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jvir.2016.06.023","volume":"28","author":"CC Pieper","year":"2017","unstructured":"Pieper CC, Jansen C, Meyer C, et al. Prospective evaluation of passive expansion of partially dilated transjugular intrahepatic portosystemic shunt stent grafts\u2014a three-dimensional sonography study. J Vasc Interv Radiol. 2017;28(1):117\u201325. https:\/\/doi.org\/10.1016\/j.jvir.2016.06.023.","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"5100_CR27","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.jhep.2012.02.011","volume":"56","author":"JF Dufour","year":"2012","unstructured":"Dufour JF. TACE with or without systemic therapy? J Hepatol. 2012;56(6):1224\u20135. https:\/\/doi.org\/10.1016\/j.jhep.2012.02.011.","journal-title":"J Hepatol"},{"issue":"5","key":"5100_CR28","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1097\/JS9.0000000000000256","volume":"109","author":"Y Yuan","year":"2023","unstructured":"Yuan Y, He W, Yang Z, et al. TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: A propensity score matching study. Int J Surg. 2023;109(5):1222\u201330. https:\/\/doi.org\/10.1097\/JS9.0000000000000256.","journal-title":"Int J Surg"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05100-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05100-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05100-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:03:05Z","timestamp":1792526585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05100-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5100"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-05100-0","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"21 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of the First Affiliated Hospital with Nanjing Medical University (2025-SR-657). The study was conducted as a retrospective analysis and, therefore, was exempt from the requirement for informed consent in accordance with applicable institutional ethics committee review board policies.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"679"}}